In this paper, a new digitally controlled linear-in-dB CMOS variable gain amplifier is proposed. The circuit employs the proposed novel approach in achieving a wide-range true-exponential transfer function e 2X using a traditional pseudoexponential amplifier followed by a variable gain stage, to expand the output dynamic range. A single digitally controlled variable resistor is used to tune the circuit accordingly by controlling X with a digital word. The result is a digitally controlled data conversion that yields a new type of non-linear digital-to-analog converter. Finally, a 4-bit converter is implemented in a TSMC 0.18 µm CMOS technology and displays a gain from about −21 dB to 36 dB in steps of 3.89 dB with an output linear error in [−0.66, 0.45] dB and a static power consumption of 2.34 mW.
This brief presents an 84-dB dynamic range true logarithmic amplifier. Logarithmic ordering in the output is achieved as a function of control parameter X , which in turn is tuned digitally. The result is a digitally controlled data conversion that yields a new type of logarithmic digital-to-analog converter. This 4-bit nonlinear converter has been fabricated in a TSMC 0.18-μm complimentary metal-oxide-semiconductor technology. Measurement results confirm theory and simulations, and display logarithmic transfer characteristics within [−1.36%, 0.84%] output linear error. The integrated circuit has dimensions of 1.5 × 1 mm 2 and an average power consumption of 13.2 mW when powered with ±1.65-V supply voltages.Index Terms-Digitally controlled variable resistor, dynamic range (DR) expansion, logarithmic digital-to-analog converter (DAC), pseudologarithmic amplifier, variable gain amplifier.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.